Severe vitamin D deficiency in preterm infants: maternal and neonatal clinical features

Sook-Hyun Park1, Gi-Min Lee1, Jung-Eun Moon1

  • 1Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea.

Insights

Most preterm infants have insufficient vitamin D levels, with nearly half experiencing severe deficiency. Twin infants and those born in winter face higher risks of severe vitamin D deficiency.

Area of Science:

  • Neonatal Medicine
  • Pediatric Nutrition
  • Endocrinology

Background:

  • Vitamin D is crucial for infant health, particularly bone development and immune function.
  • Preterm infants are at increased risk for vitamin D deficiency due to various factors.
  • Assessing vitamin D status in this vulnerable population is essential for timely intervention.

Purpose of the Study:

  • To determine the incidence and severity of vitamin D deficiency in preterm infants.
  • To investigate the correlation between vitamin D status and gestational age.
  • To identify risk factors for vitamin D deficiency in preterm neonates.

Main Methods:

  • Serum concentrations of 25-hydroxyvitamin D (25-OHD), calcium, phosphorous, and alkaline phosphatase were measured at birth in 278 preterm infants.
  • Maternal and neonatal data, including gestational age and birth weight, were collected.
  • Statistical analysis was performed to assess the incidence of deficiency and identify associated factors.

Main Results:

  • A high incidence of vitamin D deficiency (91.7%) was observed, with 51.1% of infants having severe deficiency (25-OHD < 10 ng/mL).
  • Gestational age did not correlate with 25-OHD concentrations or the incidence of severe deficiency.
  • Twin preterm infants had a significantly higher risk of severe vitamin D deficiency (OR, 1.993; P=0.016).
  • Severe vitamin D deficiency was less common in the fall compared to winter (P=0.024).

Conclusions:

  • The vast majority of preterm infants (98.9%) exhibit vitamin D insufficiency, with half experiencing severe deficiency.
  • While younger gestational age was not a direct risk factor, gestational number was associated with severe deficiency.
  • Findings highlight the critical need for monitoring and potential supplementation of vitamin D in preterm infants.
Abstract

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.8K
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
3.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
738
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
6.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704